Literature DB >> 22661228

Early and late steps in telomere overhang processing in normal human cells: the position of the final RNA primer drives telomere shortening.

Tracy T Chow1, Yong Zhao, Sabrina S Mak, Jerry W Shay, Woodring E Wright.   

Abstract

Telomere overhangs are essential for telomere end protection and telomerase extension, but how telomere overhangs are generated is unknown. Leading daughter strands synthesized by conventional semiconservation DNA replication are initially blunt, while lagging daughter strands are shorter by at least the size of the final RNA primer, which is thought to be located at extreme chromosome ends. We developed a variety of new approaches to define the steps in the processing of these overhangs. We show that the final lagging RNA primer is not terminal but is randomly positioned ~70-100 nucleotides from the ends and is not removed for more than an hour. This identifies an important intrinsic step in replicative aging. Telomeric termini are processed in two distinct phases. During the early phase, which occupies 1-2 h following replication of the duplex telomeric DNA, several steps occur on both leading and lagging daughters. Leading telomere processing remains incomplete until late S/G2, when the C-terminal nucleotide is specified-referred to as the late phase. These observations suggest the presence of previously unsuspected complexes and signaling events required for the replication of the ends of human chromosomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661228      PMCID: PMC3371406          DOI: 10.1101/gad.187211.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  63 in total

1.  Progressive cis-inhibition of telomerase upon telomere elongation.

Authors:  S Marcand; V Brevet; E Gilson
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Functional human telomeres are recognized as DNA damage in G2 of the cell cycle.

Authors:  Ramiro E Verdun; Laure Crabbe; Candy Haggblom; Jan Karlseder
Journal:  Mol Cell       Date:  2005-11-23       Impact factor: 17.970

3.  Defective telomere lagging strand synthesis in cells lacking WRN helicase activity.

Authors:  Laure Crabbe; Ramiro E Verdun; Candy I Haggblom; Jan Karlseder
Journal:  Science       Date:  2004-12-10       Impact factor: 47.728

4.  The involvement of the Mre11/Rad50/Nbs1 complex in the generation of G-overhangs at human telomeres.

Authors:  Weihang Chai; Agnel J Sfeir; Hirotoshi Hoshiyama; Jerry W Shay; Woodring E Wright
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

5.  TRF2 protects human telomeres from end-to-end fusions.

Authors:  B van Steensel; A Smogorzewska; T de Lange
Journal:  Cell       Date:  1998-02-06       Impact factor: 41.582

6.  Normal human chromosomes have long G-rich telomeric overhangs at one end.

Authors:  W E Wright; V M Tesmer; K E Huffman; S D Levene; J W Shay
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

7.  Telomere-end processing the terminal nucleotides of human chromosomes.

Authors:  Agnel J Sfeir; Weihang Chai; Jerry W Shay; Woodring E Wright
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

8.  Mammalian telomeres end in a large duplex loop.

Authors:  J D Griffith; L Comeau; S Rosenfield; R M Stansel; A Bianchi; H Moss; T de Lange
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

9.  Human telomeres have different overhang sizes at leading versus lagging strands.

Authors:  Weihang Chai; Qun Du; Jerry W Shay; Woodring E Wright
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

10.  Normal human telomeres are not late replicating.

Authors:  W E Wright; V M Tesmer; M L Liao; J W Shay
Journal:  Exp Cell Res       Date:  1999-09-15       Impact factor: 3.905

View more
  52 in total

1.  Telomere end processing: unexpected complexity at the end game.

Authors:  Victoria Lundblad
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

Review 2.  Telomere biology: Rationale for diagnostics and therapeutics in cancer.

Authors:  Philippe Rousseau; Chantal Autexier
Journal:  RNA Biol       Date:  2015-08-20       Impact factor: 4.652

3.  Dynamics of Human Telomerase Holoenzyme Assembly and Subunit Exchange across the Cell Cycle.

Authors:  Jacob M Vogan; Kathleen Collins
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

4.  Telomere-end processing: mechanisms and regulation.

Authors:  Diego Bonetti; Marina Martina; Marco Falcettoni; Maria Pia Longhese
Journal:  Chromosoma       Date:  2013-10-12       Impact factor: 4.316

5.  Chromosome end protection by blunt-ended telomeres.

Authors:  Anita Kazda; Barbara Zellinger; Max Rössler; Elisa Derboven; Branislav Kusenda; Karel Riha
Journal:  Genes Dev       Date:  2012-07-18       Impact factor: 11.361

6.  Blunt-ended telomeres: an alternative ending to the replication and end protection stories.

Authors:  Andrew D L Nelson; Dorothy E Shippen
Journal:  Genes Dev       Date:  2012-08-01       Impact factor: 11.361

Review 7.  The role of double-strand break repair pathways at functional and dysfunctional telomeres.

Authors:  Ylli Doksani; Titia de Lange
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-16       Impact factor: 10.005

8.  Single-strand DNA-binding protein SSB1 facilitates TERT recruitment to telomeres and maintains telomere G-overhangs.

Authors:  Raj K Pandita; Tracy T Chow; Durga Udayakumar; Amanda L Bain; Liza Cubeddu; Clayton R Hunt; Wei Shi; Nobuo Horikoshi; Yong Zhao; Woodring E Wright; Kum Kum Khanna; Jerry W Shay; Tej K Pandita
Journal:  Cancer Res       Date:  2015-01-14       Impact factor: 12.701

Review 9.  Mechanisms of DNA replication termination.

Authors:  James M Dewar; Johannes C Walter
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-24       Impact factor: 94.444

10.  BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.

Authors:  Shu Wu; Yuanlong Ge; Laiqiang Huang; Haiying Liu; Yong Xue; Yong Zhao
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.